Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial-Reference-Cited by-同舟云学术

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Published:2009-08 Issue:9688 Volume:374 Page:459-466
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

van Vollenhoven RF,Ernestam S,Geborek P,Petersson IF,Cöster L,Waltbrand E,Zickert A,Theander J,Thörner Å,Hellström H,Teleman A,Dackhammar C,Akre F,Forslind K,Ljung L,Oding R,Chatzidionysiou A,Wörnert M,Bratt J

Funder

Reumatikerförbundet

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

2. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial;Emery;Lancet,2008

3. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial;St Clair;Arthritis Rheum,2004

4. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis;Wessels;Arthritis Rheum,2007

5. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial;RMD Open;2024-08

2. Translation of cell therapies to treat autoimmune disorders;Advanced Drug Delivery Reviews;2024-02

3. Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study;Journal of Clinical Medicine;2024-01-11

4. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial;Annals of the Rheumatic Diseases;2023-07-09

5. Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort;Rheumatology and Therapy;2023-05-14